A Novel Healthcare Information Technology Tool to Improve Care in Patients With Atrial Fibrillation
|2||Active, not recruiting||
BNP Pharmacodynamics and Effects on Metabolism in Lean and Obese Subjects
Regadenoson Stress-MRI to Identify Coronary Artery Disease in Atrial Fibrillation Patients
Opportunistic Screening in Pharmacies for Atrial Fibrillation in Seniors (>65 Years)
Left Atrial Appendage Closure vs. Novel Anticoagulation Agents in Atrial Fibrillation
† Study has passed its completion date and status has not been verified in more than two years.